Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers

Maria Elena Romero-Ibarguengoitia; Arnulfo González Cantú; Yodira Guadalupe Hernández-Ruíz; Ana Gabriela Amerndariz-Vázquez; Diego Rivera-Salinas; Laura Patricia Montelongo-Cruz; Gerardo Francisco del Río-Parra; Irene Antonieta Barco-Flores; Rosalinda González-Facio; Miguel Ángel Sanz-Sánchez

doi:10.1101/2021.10.07.21264657

Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers

Maria Elena Romero-Ibarguengoitia, Arnulfo González Cantú, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Amerndariz-Vázquez, Diego Rivera-Salinas, Laura Patricia Montelongo-Cruz, Gerardo Francisco del Río-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Miguel Ángel Sanz-Sánchez

Especialidades Médicas

Research output: Other contribution

Original language	English
DOIs	https://doi.org/10.1101/2021.10.07.21264657
Publication status	Published - 11 Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1101/2021.10.07.21264657

Cite this

Romero-Ibarguengoitia, M. E., Cantú, A. G., Hernández-Ruíz, Y. G., Amerndariz-Vázquez, A. G., Rivera-Salinas, D., Montelongo-Cruz, L. P., Río-Parra, G. F. D., Barco-Flores, I. A., González-Facio, R., & Sanz-Sánchez, M. Á. (2021, Oct 11). Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers. https://doi.org/10.1101/2021.10.07.21264657

@misc{80efdab71f3b42e3a7cae7badc6ee20d,

title = "Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers",

author = "Romero-Ibarguengoitia, {Maria Elena} and Cant{\'u}, {Arnulfo Gonz{\'a}lez} and Hern{\'a}ndez-Ru{\'i}z, {Yodira Guadalupe} and Amerndariz-V{\'a}zquez, {Ana Gabriela} and Diego Rivera-Salinas and Montelongo-Cruz, {Laura Patricia} and R{\'i}o-Parra, {Gerardo Francisco del} and Barco-Flores, {Irene Antonieta} and Rosalinda Gonz{\'a}lez-Facio and Sanz-S{\'a}nchez, {Miguel {\'A}ngel}",

year = "2021",

month = oct,

day = "11",

doi = "10.1101/2021.10.07.21264657",

language = "English",

type = "Other",

}

Romero-Ibarguengoitia, ME , Cantú, AG, Hernández-Ruíz, YG, Amerndariz-Vázquez, AG, Rivera-Salinas, D, Montelongo-Cruz, LP, Río-Parra, GFD, Barco-Flores, IA, González-Facio, R & Sanz-Sánchez, MÁ 2021, Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers.. https://doi.org/10.1101/2021.10.07.21264657

TY - GEN

T1 - Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers

AU - Romero-Ibarguengoitia, Maria Elena

AU - Cantú, Arnulfo González

AU - Hernández-Ruíz, Yodira Guadalupe

AU - Amerndariz-Vázquez, Ana Gabriela

AU - Rivera-Salinas, Diego

AU - Montelongo-Cruz, Laura Patricia

AU - Río-Parra, Gerardo Francisco del

AU - Barco-Flores, Irene Antonieta

AU - González-Facio, Rosalinda

AU - Sanz-Sánchez, Miguel Ángel

PY - 2021/10/11

Y1 - 2021/10/11

UR - https://doi.org/10.1101/2021.10.07.21264657

U2 - 10.1101/2021.10.07.21264657

DO - 10.1101/2021.10.07.21264657

M3 - Other contribution

ER -

Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers

UN SDGs

Access to Document

Other files and links

Cite this